These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Adipocytokines in systemic lupus erythematosus: relationship to inflammation, insulin resistance and coronary atherosclerosis. Chung CP; Long AG; Solus JF; Rho YH; Oeser A; Raggi P; Stein CM Lupus; 2009 Aug; 18(9):799-806. PubMed ID: 19578104 [TBL] [Abstract][Full Text] [Related]
23. Adipocytokines in Non-functional Adrenal Incidentalomas and Relation with Insulin Resistance Parameters. Akkus G; Evran M; Sert M; Tetiker T Endocr Metab Immune Disord Drug Targets; 2019; 19(3):326-332. PubMed ID: 30306882 [TBL] [Abstract][Full Text] [Related]
24. Adipose expression of adipocytokines in women with polycystic ovary syndrome. Svendsen PF; Christiansen M; Hedley PL; Nilas L; Pedersen SB; Madsbad S Fertil Steril; 2012 Jul; 98(1):235-41. PubMed ID: 22607892 [TBL] [Abstract][Full Text] [Related]
25. Leptin, adiponectin, resistin, visfatin serum levels and idiopathic recurrent pericarditis: biomarkers of disease activity? A preliminary report. Cantarini L; Brucato A; Simonini G; Imazio M; Cumetti D; Cimaz R; Bacarelli MR; Muscari I; Vitale A; Lucherini OM; Galeazzi M; Fioravanti A Clin Exp Rheumatol; 2013; 31(2):207-12. PubMed ID: 23137677 [TBL] [Abstract][Full Text] [Related]
26. Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Nakajima TE; Yamada Y; Hamano T; Furuta K; Matsuda T; Fujita S; Kato K; Hamaguchi T; Shimada Y Cancer Sci; 2010 May; 101(5):1286-91. PubMed ID: 20331631 [TBL] [Abstract][Full Text] [Related]
28. Splanchnic concentrations and postprandial release of visceral adipokines. Wiest R; Moleda L; Farkas S; Scherer M; Kopp A; Wönckhaus U; Büchler C; Schölmerich J; Schäffler A Metabolism; 2010 May; 59(5):664-70. PubMed ID: 19913846 [TBL] [Abstract][Full Text] [Related]
29. Differential Association of Selected Adipocytokines, Adiponectin, Leptin, Resistin, Visfatin and Chemerin, with the Pathogenesis and Progression of Type 2 Diabetes Mellitus (T2DM) in the Asir Region of Saudi Arabia: A Case Control Study. Mir MM; Mir R; Alghamdi MAA; Wani JI; Sabah ZU; Jeelani M; Marakala V; Sohail SK; O'haj M; Alharthi MH; Alamri MMS J Pers Med; 2022 May; 12(5):. PubMed ID: 35629157 [TBL] [Abstract][Full Text] [Related]
30. Serum levels of visfatin, resistin and adiponectin in patients with psoriatic arthritis and associations with disease severity. Dikbas O; Tosun M; Bes C; Tonuk SB; Aksehirli OY; Soy M Int J Rheum Dis; 2016 Jul; 19(7):672-7. PubMed ID: 25196858 [TBL] [Abstract][Full Text] [Related]
31. Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease. Eker S; Ayaz L; Tamer L; Ulubas B Scand J Clin Lab Invest; 2010 Feb; 70(1):40-4. PubMed ID: 20021311 [TBL] [Abstract][Full Text] [Related]
32. Adipocytokines and squamous cell carcinoma of the esophagus. Nakajima TE; Yamada Y; Hamano T; Furuta K; Oda I; Kato H; Kato K; Hamaguchi T; Shimada Y J Cancer Res Clin Oncol; 2010 Feb; 136(2):261-6. PubMed ID: 19693538 [TBL] [Abstract][Full Text] [Related]
33. Maternal and cord blood apelin, resistin and visfatin levels in gestational diabetes mellitus. Oncul M; Tuten A; Erman H; Gelisgen R; Benian A; Uzun H Minerva Med; 2013 Oct; 104(5):527-35. PubMed ID: 24101110 [TBL] [Abstract][Full Text] [Related]
34. Serum visfatin levels in acromegaly: Correlation with disease activity and metabolic alterations. Ciresi A; Amato MC; Pizzolanti G; Giordano C Growth Horm IGF Res; 2015 Oct; 25(5):240-6. PubMed ID: 26188992 [TBL] [Abstract][Full Text] [Related]
35. Resistin, visfatin, leptin and omentin are differently related to hormonal and metabolic parameters in growth hormone-deficient children. Ciresi A; Pizzolanti G; Leotta M; Guarnotta V; Teresi G; Giordano C J Endocrinol Invest; 2016 Sep; 39(9):1023-30. PubMed ID: 27126309 [TBL] [Abstract][Full Text] [Related]
36. The effects of topiramate and valproate therapy on insulin, c-peptide, leptin, neuropeptide Y, adiponectin, visfatin, and resistin levels in children with epilepsy. Sonmez FM; Zaman D; Aksoy A; Deger O; Aliyazicioglu R; Karaguzel G; Fazlioglu K Seizure; 2013 Dec; 22(10):856-61. PubMed ID: 23937963 [TBL] [Abstract][Full Text] [Related]
37. Adipohormones as prognostric markers in patients with nonalcoholic steatohepatitis (NASH). Krawczyk K; Szczesniak P; Kumor A; Jasinska A; Omulecka A; Pietruczuk M; Orszulak-Michalak D; Sporny S; Malecka-Panas E J Physiol Pharmacol; 2009 Oct; 60 Suppl 3():71-5. PubMed ID: 19996485 [TBL] [Abstract][Full Text] [Related]
38. Pro-inflammatory adipokine profile in psoriatic arthritis: results from a cross-sectional study comparing PsA subset with evident cutaneous involvement and subset "sine psoriasis". Caso F; Postiglione L; Covelli B; Ricciardone M; Di Spigna G; Formisano P; D'Esposito V; Girolimetto N; Tasso M; Peluso R; Navarini L; Ciccozzi M; Margiotta DPE; Oliviero F; Afeltra A; Punzi L; Del Puente A; Scarpa R; Costa L Clin Rheumatol; 2019 Sep; 38(9):2547-2552. PubMed ID: 31147798 [TBL] [Abstract][Full Text] [Related]
40. Serum adipokine levels in rheumatoid arthritis patients and their contributions to the resistance to treatment. Kim KS; Choi HM; Ji HI; Song R; Yang HI; Lee SK; Yoo MC; Park YB Mol Med Rep; 2014 Jan; 9(1):255-60. PubMed ID: 24173909 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]